New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on: January 11,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on:January 11,2024

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on: March 14,2024

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on:March 14,2024

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the

Updated on: March 30,2024

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the

Updated on:March 30,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

Spread of deadly eye cancer halted in cells and animals

by Johns Hopkins University School of MedicineGreen retinoblastoma cells in a zebra fish eye. Credit: David White, Jeff MummBy comparing genetic sequences in the eye tumors of children whose canc

Updated on: April 09,2024

Spread of deadly eye cancer halted in cells and animals

by Johns Hopkins University School of MedicineGreen retinoblastoma cells in a zebra fish eye. Credit: David White, Jeff MummBy comparing genetic sequences in the eye tumors of children whose canc

Updated on:April 09,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C

Updated on: January 30,2024

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C

Updated on:January 30,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on: October 24,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on:October 24,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on: April 09,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on:April 09,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on: January 07,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on:January 07,2024

Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

byWileyCredit: Pixabay/CC0 Public DomainA technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately ai

Updated on: January 07,2024

Image-guided adaptive radiation treatments reduce short-term side effects for patients with prostate cancer

byWileyCredit: Pixabay/CC0 Public DomainA technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately ai

Updated on:January 07,2024